Oral antifungal medication for toenail onychomycosis

  • Protocol
  • Intervention

Authors

  • Sanne Kreijkamp-Kaspers,

    Corresponding author
    1. The University of Queensland, Discipline of General Practice, School of Medicine, Brisbane, Herston, Queensland, Australia
    • Sanne Kreijkamp-Kaspers, Discipline of General Practice, School of Medicine, The University of Queensland, Level 8, Health Sciences Building 16/910, Royal Brisbane & Women's Hospital Complex, Brisbane, Herston, Queensland, 4029, Australia. s.kreijkampkaspers@uq.edu.au.

    Search for more papers by this author
  • Sally EM Bell-Syer,

    1. University of York, Department of Health Sciences, York, North Yorkshire, UK
    Search for more papers by this author
  • Parker Magin,

    1. The University of Newcastle, Discipline of General Practice, School of Medicine and Public Health, Callaghan, Australia
    Search for more papers by this author
  • Sophie V Bell-Syer,

    1. Keele University, Keele University Medical School, Keele, Staffordshire, UK
    Search for more papers by this author
  • Mieke L van Driel

    1. The University of Queensland, Discipline of General Practice, School of Medicine, Brisbane, Herston, Queensland, Australia
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the benefits and harms of oral antifungal treatments for toenail onychomycosis.